Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial

Mercoledì 9 marzo 2022

circa 1 minuti di lettura

Journal and Affiliations:

EuroIntervention, 9 marzo 2022

Marco Valgimigli, Cardiocentro Ticino e Università della Svizzera italiana, Lugano

Tags:

aspirin monotherapy

dual antiplatelet therapy

percutaneous coronary intervention

ticagrelor monotherapy

Authors:

Marco Valgimigli

Link: https://pubmed.ncbi.nlm.nih.gov/35260381/